đź“‹ FDA Reference
philips medio cp family
Philips Medical Systems
Summary: The Philips Medio CP Family is a Class 1 medical device used for embolization procedures. It is primarily utilized by interventional radiologists to manage vascular conditions.
FDA Clearance Information
Pathway
510K
Number
K925105 ↗
Decision Date
December 28, 1992
Product Code
IZO
Device Class
Class 1
Evidence
419 studies
The Philips Medio CP Family was cleared via the FDA 510(k) pathway on December 28, 1992. Manufactured by Philips Medical Systems, it is classified as a Class 1 device under product code IZO.
What It Is
The Philips Medio CP Family consists of liquid agents used in embolization procedures. These agents are designed to occlude blood vessels, thereby controlling or preventing abnormal blood flow. This device is typically employed in minimally invasive procedures where precise embolization is required, leveraging its liquid nature for effective vascular occlusion.
Clinical Applications
Commonly used in interventional radiology, the Philips Medio CP Family is employed in procedures such as treating arteriovenous malformations, controlling bleeding, and pre-surgical embolization of tumors. It is particularly useful in settings that require precise vascular intervention, such as hospitals and specialized outpatient centers, and is suitable for a wide range of patient populations, including those with vascular abnormalities.
Indications for Use
The FDA indications for the Philips Medio CP Family involve its use in embolization, which is a technique to block blood vessels. This is typically indicated for patients with conditions like vascular malformations, tumors requiring reduced blood supply, or instances of acute bleeding.
Practical Considerations
The Philips Medio CP Family is available in various formulations to suit different procedural needs. Clinicians should consider the viscosity and flow characteristics of the liquid agents when planning embolization. Compatibility with standard catheter systems is generally expected, facilitating ease of use in typical interventional settings.
Linked Studies (20)
PubMed • 2025
Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.
Journal of neuroendovascular therapy
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.
Clinical chemistry and laboratory medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical progress note: Haemophilus influenzae type b.
Journal of hospital medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Pilot study of social media promotion of home-based self-testing for syphilis.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.
Journal of clinical microbiology
View Source →
PubMed • 2025
Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.
Florida public health review
View Source →
PubMed • 2025
Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.
Frontiers in cellular and infection microbiology
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.
Transboundary and emerging diseases
View Source →
PubMed • 2025
Tp40: a new potential prognostic and diagnostic marker for syphilis.
Microbiology spectrum
View Source →
PubMed • 2025
Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.
The Journal of clinical investigation
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.
Hellenic journal of nuclear medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.
Biochemistry and cell biology = Biochimie et biologie cellulaire
View Source →
PubMed • 2025
Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.
Journal of Yeungnam medical science
RCT View Source →
PubMed • 2025
pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.
Magnetic resonance in medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Comparative connectomics of Drosophila descending and ascending neurons.
Nature
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
View Source →
PubMed • 2025
History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.
Zeitschrift fur Rheumatologie
View Source →
PubMed • 2025
A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.
BioMed research international
RCT|prospective|retrospective|case Series|other View Source →Frequently Asked Questions
What is Philips Medio CP Family used for?
The Philips Medio CP Family is used for embolization procedures to occlude blood vessels and manage abnormal blood flow.
What specialties typically use this device?
Interventional radiologists primarily use this device in vascular and oncological procedures.
What are the FDA-cleared indications?
The device is indicated for use in embolization to block blood vessels in conditions like vascular malformations and tumors.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.